Collegium Pharmaceutical, Inc. (COLL)
25.35
-1.09
(-4.12%)
USD |
NASDAQ |
Aug 28, 16:00
25.35
0.00 (0.00%)
After-Hours: 20:00
Collegium Pharmaceutical Total Return Price : 25.35 for Aug. 28, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| August 27, 2026 | 26.44 |
| August 26, 2026 | 27.51 |
| August 25, 2026 | 27.47 |
| August 24, 2026 | 27.35 |
| August 21, 2026 | 27.11 |
| August 20, 2026 | 27.54 |
| August 19, 2026 | 28.74 |
| August 18, 2026 | 28.50 |
| August 17, 2026 | 28.07 |
| August 14, 2026 | 28.23 |
| August 13, 2026 | 28.15 |
| August 12, 2026 | 25.70 |
| August 11, 2026 | 25.98 |
| August 10, 2026 | 27.20 |
| August 07, 2026 | 29.47 |
| August 06, 2026 | 29.11 |
| August 05, 2026 | 35.74 |
| August 04, 2026 | 35.73 |
| August 03, 2026 | 35.58 |
| July 31, 2026 | 35.39 |
| July 30, 2026 | 35.98 |
| July 29, 2026 | 36.29 |
| July 28, 2026 | 35.90 |
| July 27, 2026 | 35.52 |
| July 24, 2026 | 35.20 |
| Date | Value |
|---|---|
| July 23, 2026 | 35.59 |
| July 22, 2026 | 34.72 |
| July 21, 2026 | 35.85 |
| July 20, 2026 | 35.54 |
| July 17, 2026 | 36.08 |
| July 16, 2026 | 36.27 |
| July 15, 2026 | 36.72 |
| July 14, 2026 | 35.02 |
| July 13, 2026 | 34.82 |
| July 10, 2026 | 35.23 |
| July 09, 2026 | 35.81 |
| July 08, 2026 | 35.83 |
| July 07, 2026 | 36.44 |
| July 06, 2026 | 37.47 |
| July 02, 2026 | 37.03 |
| July 01, 2026 | 35.87 |
| June 30, 2026 | 36.20 |
| June 29, 2026 | 35.98 |
| June 26, 2026 | 36.59 |
| June 25, 2026 | 34.84 |
| June 24, 2026 | 35.58 |
| June 23, 2026 | 34.62 |
| June 22, 2026 | 33.45 |
| June 18, 2026 | 33.54 |
| June 17, 2026 | 33.68 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Innoviva, Inc. | 20.98 |
| Zevra Therapeutics, Inc. | 11.56 |
| Supernus Pharmaceuticals, Inc. | 43.74 |
| Indivior Pharmaceuticals, Inc. | 34.87 |
| Crinetics Pharmaceuticals, Inc. | 84.85 |